Market Research Logo

Refocus Group Inc - Product Pipeline Analysis, 2017 Update

Summary

Refocus Group Inc (Refocus Group) is a medical equipment company that concentrates on research and development of treatments for human vision disorders. The company has developed visability implant system (VIS) for the treatment of presbyopia. Its VIS procedure is an outpatient procedure that involves implantation. It VIS implants provides treatment for presbyopia that restores natural ability to focus at near and intermediate distances. The implants are designed for focusing that muscles work better to improve near vision. It offers various surgical options for treatment that offers maintains cornea and lens integrity and others. It markets products in the US and Canada. Refocus Group is headquartered at Dallas, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Refocus Group Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Refocus Group Inc Company Overview
Refocus Group Inc Company Snapshot
Refocus Group Inc Pipeline Products and Ongoing Clinical Trials Overview
Refocus Group Inc – Pipeline Analysis Overview
Refocus Group Inc - Key Facts
Refocus Group Inc - Major Products and Services
Refocus Group Inc Pipeline Products by Development Stage
Refocus Group Inc Ongoing Clinical Trials by Trial Status
Refocus Group Inc Pipeline Products Overview
PresVIEW Scleral Implant - Glaucoma
PresVIEW Scleral Implant - Glaucoma Product Overview
PresVIEW Scleral Implant - Presbyopia
PresVIEW Scleral Implant - Presbyopia Product Overview
VisAbility Implant System
VisAbility Implant System Product Overview
VisAbility Implant System Clinical Trial
Refocus Group Inc - Key Competitors
Refocus Group Inc - Key Employees
Refocus Group Inc - Locations And Subsidiaries
Head Office
Recent Developments
Refocus Group Inc, Recent Developments
May 05, 2016: Refocus Group Completes Phase 3 Clinical Trial on the VisAbility Micro-Insert System for Presbyopia; Raises Additional Funding
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Refocus Group Inc Pipeline Products and Ongoing Clinical Trials Overview
Refocus Group Inc Pipeline Products by Equipment Type
Refocus Group Inc Pipeline Products by Indication
Refocus Group Inc Ongoing Clinical Trials by Trial Status
Refocus Group Inc, Key Facts
Refocus Group Inc, Major Products and Services
Refocus Group Inc Number of Pipeline Products by Development Stage
Refocus Group Inc Pipeline Products Summary by Development Stage
Refocus Group Inc Ongoing Clinical Trials by Trial Status
Refocus Group Inc Ongoing Clinical Trials Summary
PresVIEW Scleral Implant - Glaucoma - Product Status
PresVIEW Scleral Implant - Glaucoma - Product Description
PresVIEW Scleral Implant - Presbyopia - Product Status
PresVIEW Scleral Implant - Presbyopia - Product Description
VisAbility Implant System - Product Status
VisAbility Implant System - Product Description
VisAbility Implant System - A Prospective, Multicenter Clinical Trial of the VisAbility Implant System for Improvement of Near Visual Acuity in Presbyopic Patients
Refocus Group Inc, Key Employees
Glossary
List of Figures
Refocus Group Inc Pipeline Products by Equipment Type
Refocus Group Inc Pipeline Products by Development Stage
Refocus Group Inc Ongoing Clinical Trials by Trial Status

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report